Literature DB >> 7892763

White matter lesions and cognitive deficits: relevance of lesion pattern?

M S Damian1, G Schilling, G Bachmann, C Simon, S Stöppler, W Dorndorf.   

Abstract

Magnetic resonance imaging (MRI) permits efficient visualization of white matter lesions (WML). A growing body of literature deals with the correlation of WML and cognitive dysfunction with conflicting results. We studied the influence of lesion pattern as well as size by analyzing MRI and psychometric test performance in 2 patient collectives with different WML patterns. 22 patients with myotonic dystrophy (MD) and mainly subcortical WML were compared with 39 patients with multiple sclerosis (MS) and mainly periventricular lesions. 73% of MD patients had WML, the extent of which correlated with cognitive deficits. Severely impaired patients had psychometric findings compatible with "subcortical" dementia. In MS the extent of WML alone did not correlate significantly with cognitive deficits. Significant cognitive dysfunction was observed with extension of WML to areas of white matter immediately underlying cortex, but not with exclusively periventricular lesions. Cerebral atrophy had less impact. Comparison of MD and MS indicates that WML immediately subjacent to cortex are likely to cause significant cognitive deficits, whereas extensive periventricular demyelination may cause no major dysfunction. This may relate to early disturbance of associative fibers by subcortical lesions. Our results emphasize the significance of pattern as well as total extent of WML. Myotonic dystrophy is a useful model to study the effect of subcortical lesions, due to a typical lesion pattern unusual in other conditions.

Entities:  

Mesh:

Year:  1994        PMID: 7892763     DOI: 10.1111/j.1600-0404.1994.tb02753.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  Cerebral and muscle MRI abnormalities in myotonic dystrophy.

Authors:  Daniel T Franc; Ryan L Muetzel; Paul R Robinson; Craig P Rodriguez; Joline C Dalton; Cameron E Naughton; Bryon A Mueller; Jeffrey R Wozniak; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2012-01-30       Impact factor: 4.296

2.  White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients.

Authors:  Yongxia Zhou; Fang Yu; Timothy Q Duong
Journal:  J Magn Reson Imaging       Date:  2013-12-31       Impact factor: 4.813

3.  White matter abnormalities and neurocognitive correlates in children and adolescents with myotonic dystrophy type 1: a diffusion tensor imaging study.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Erin E Ward; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2010-12-18       Impact factor: 4.296

4.  Electroencephalographic coherence analysis in multiple sclerosis: correlation with clinical, neuropsychological, and MRI findings.

Authors:  L Leocani; T Locatelli; V Martinelli; M Rovaris; M Falautano; M Filippi; G Magnani; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

5.  Retrospective study on PET-SPECT imaging in a large cohort of myotonic dystrophy type 1 patients.

Authors:  Vincenzo Romeo; E Pegoraro; F Squarzanti; G Sorarù; C Ferrati; M Ermani; P Zucchetta; F Chierichetti; C Angelini
Journal:  Neurol Sci       Date:  2010-09-15       Impact factor: 3.307

6.  Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis.

Authors:  M Rovaris; M Filippi; L Minicucci; G Iannucci; G Santuccio; F Possa; G Comi
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

7.  Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2.

Authors:  Vincenzo Romeo; E Pegoraro; C Ferrati; F Squarzanti; G Sorarù; A Palmieri; P Zucchetta; L Antunovic; E Bonifazi; G Novelli; C P Trevisan; M Ermani; R Manara; C Angelini
Journal:  J Neurol       Date:  2010-03-11       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.